Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research
ASH, the world's
largest professional society concerned with the causes and treatments of blood
disorders, regularly issues press releases highlighting clinical and research
advances announced at the ASH annual meeting and published
in Blood, as well as releases and statements on breaking policy news
affecting the field of hematology.
Need to speak with an expert? Complete our Request An Expert form.
To be added to ASH's press release distribution list, contact Alicia Davids at firstname.lastname@example.org.
New research published online today in Blood, the Journal of the American Society of Hematology (ASH), concludes that a blood clot in an abdominal vein may be an indicator of undiagnosed cancer. The study also suggests that these clots predict poorer survival in patients with liver and pancreatic cancer.
Today Representatives Leonard Lance (R-NJ) and Brian Higgins (D-NY) and Senators Mark Kirk (R-IL) and Al Franken (D-MN) introduced the Cancer Drug Coverage Parity Act. This legislation would require private health plans with intravenous (IV) chemotherapy benefits to provide parity for orally administered and self-injectable anticancer chemotherapy medications.
Barbara Lee (D-CA) and Michael C. Burgess (R-TX) introduced a resolution in the
U.S. House of Representatives calling for expanded government efforts to
increase sickle cell trait (SCT) research and improved access to screening and
education for individuals with SCT.
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research.
Support the mission of ASH and help move hematology forward.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology